Compounded semaglutide vs FDA-approved semaglutide (2026) Updated · 14d ago
Quick answer: Compounded semaglutide is mixed by licensed compounding pharmacies, often with additives (B12, glycine) and at lower cash prices ($200-400/month). FDA-approved semaglutide (Ozempic, Wegovy) costs $935-1,349/month list but carries Novo Nordisk's quality, safety, and trial-data standards. FDA does not verify compounded products.
Clinically reviewed by Editorial Medical Review, MD, NAMS-CMP · Last updated 2026-05-25
How they work
Compounded semaglutide
Same active ingredient as Ozempic/Wegovy — semaglutide. But base, additives (B12, glycine), and concentration vary by compounding pharmacy. Quality depends on the 503A or 503B pharmacy. Not subject to FDA pre-market review of the finished product.
FDA-approved semaglutide
Branded semaglutide manufactured by Novo Nordisk under FDA cGMP (current Good Manufacturing Practice). Tested in multiple Phase III RCTs (STEP, SUSTAIN series). Insurance-coverable when indication matches (T2D for Ozempic, weight loss for Wegovy).
Available formulations
Compounded semaglutide
- Vial + syringe (most common) — patient self-draws dose
- Pre-filled syringe (some pharmacies)
- Variable concentrations (2.5 mg/mL, 5 mg/mL) — dosing confusion risk
- Often includes B12 (cyanocobalamin) or glycine "to reduce side effects" — no FDA evaluation of additive safety/efficacy
FDA-approved semaglutide
- Single-use or reusable pen with pre-set dose markings
- Ozempic: 0.25, 0.5, 1, 2 mg weekly (T2D)
- Wegovy: 0.25-2.4 mg weekly (weight loss)
- Manufactured by Novo Nordisk under FDA cGMP
Common questions(3)
Is compounded semaglutide legal?
Compounding pharmacies can legally produce semaglutide when the FDA-approved drug is on the shortage list — a process governed by sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. When semaglutide is not on the shortage list, compounded versions are not legally permissible under most state pharmacy rules.
Is compounded semaglutide safe?
Quality depends entirely on the compounding pharmacy. The FDA does not test or approve compounded products. The FDA has received multiple adverse-event reports tied to compounded GLP-1 products — primarily dosing errors due to non-standard vial concentrations. Verify the pharmacy is 503A or 503B-registered and licensed in your state.
Why is compounded semaglutide cheaper?
Compounding pharmacies skip the FDA approval process and do not pay branded drug premiums. Cash-pay typical ($200-400/month) vs $935-1,349/month list for FDA-approved versions. Insurance does not cover compounded GLP-1s.
Sources(3)
Peer-reviewed and regulatory references. External links open in new tab.